Most medical professionals agree that type 1 diabetes is an autoimmune disease, and more often than ever before we see patients in their 40’s to their late 60’s who are newly diagnosed with insulin requiring diabetes. These patients are classified as having type 2 diabetes because of characteristics such as …

If this happens in my practice, I’m sure it likely happens with your patients too. So many of our patients take metformin. They may be new to using metformin or have been taking it for many years. Either way it’s not unusual to have untoward GI side effects from taking it. They may have done fine taking it for years, so they don’t even think about it being their metformin.

Tracey D. Brown, MBA, BChE is Chief Executive Officer of the American Diabetes Association (ADA), the nation’s largest voluntary health organization and a global authority on diabetes. Tracey joined the ADA in June 2018 after her tenure as senior vice president of operations and chief experience officer at Sam's Club, a division of Walmart, Inc., where she was responsible for creating meaningful member experiences, directing member strategy, marketing and branding, go-to-market execution, data and analytics and membership operations.

In this week's Homerun Slides, another question from the Adrenal category in Dr. Claude Lardinois' Endocrinology Jeopardy! This week's clue: 44-year-old male with hypertension, headache, tachycardia, and hyperhidrosis.

Genes and environment: a moving target? Studies from multiple populations have shown shifts of the typical HLA class II gene associations during the last few decades. Indeed, fewer patients carry the high risk heterozygous HLA-DR/DQ genotype, except among younger children [59–63], in whom the disease is becoming more common [4]. In contrast, more patients now carry moderate risk HLA types and genotypes. Such shifts in HLA associations may be explained by stronger environmental pressures that enhance HLA-mediated genetic predisposition and/or broaden the spectrum of diabetogenic gene–environment interactions. Viruses, and especially enteroviruses, rank at the top of the list of environmental factors that have been linked to T1DM.

In this Exclusive Interview transcript, Tracey Brown talks with Diabetes in Control Publisher Steve Freed during the ADA 2018 convention in Orlando about the start of her journey to working toward a diabetes cure, becoming CEO of the ADA, and her vision for the ADA.

In this Exclusive Interview, Tracey Brown talks with Diabetes in Control Publisher Steve Freed during the ADA 2018 convention in Orlando about the start of her journey to working toward a diabetes cure, becoming CEO of the ADA, and her vision for the ADA.

In part 1 of this Exclusive Interview, Tracey Brown shares her epiphany as a person with type 2 diabetes in a conversation with Diabetes in Control Publisher Steve Freed.

In part 2 of this Exclusive Interview, Tracey Brown explains her varied stops along her road to becoming the CEO of the ADA in a conversation with Diabetes in Control Publisher Steve Freed.

In part 3 of this Exclusive Interview, Tracey Brown talks with Diabetes in Control Publisher Steve Freed about her vision for the ADA and the need to educate and increase awareness.